NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 82 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q3 2013. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $79,000 | -10.2% | 59,600 | 0.0% | 0.00% | – |
| Q2 2014 | $88,000 | -20.0% | 59,600 | 0.0% | 0.00% | – |
| Q1 2014 | $110,000 | -10.6% | 59,600 | 0.0% | 0.00% | – |
| Q4 2013 | $123,000 | -22.2% | 59,600 | 0.0% | 0.00% | – |
| Q3 2013 | $158,000 | +8.2% | 59,600 | +9.2% | 0.00% | – |
| Q2 2013 | $146,000 | – | 54,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sowell Financial Services LLC | 506,634 | $190,000 | 0.05% |
| Harel Insurance Investments & Financial Services Ltd. | 780,000 | $328,000 | 0.02% |
| LifePlan Financial Group, Inc | 28,810 | $12,000 | 0.01% |
| AURORA FINANCIAL ADVISORS, LLC | 32,500 | $11,000 | 0.01% |
| WEDBUSH SECURITIES INC | 169,000 | $61,000 | 0.01% |
| Greenwich Wealth Management LLC | 60,066 | $22,000 | 0.00% |
| Jacobi Capital Management LLC | 20,130 | $8,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 649,880 | $233,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 436,272 | $156,000 | 0.00% |
| McCollum Christoferson Group LLC | 17,155 | $6,000 | 0.00% |